Search - tctmd.com

Displaying 121 - 140 of 427

Sort: Relevancy | Date

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Industry News

Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe

March 22, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Industry News

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

February 20, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

L.A. McKeown

February 07, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Advertisement

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Sex Differences Diminish With Third-Generation TAVR Device

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content